| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyclo Therapeutics, Inc. | Director | Common Stock | 64,853 | $40,857 | $0.6300 | 27 Feb 2025 | Direct |
| Cyclo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15,562 | 03 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CYTH | Cyclo Therapeutics, Inc. | 27 Feb 2025 | 1 | $0 | 4 | Director | 03 Mar 2025, 11:45 |
| CYTH | Cyclo Therapeutics, Inc. | 15 Nov 2024 | 1 | $0 | 4 | Director | 18 Nov 2024, 14:08 |
| CYTH | Cyclo Therapeutics, Inc. | 16 Aug 2024 | 1 | $0 | 4 | Director | 20 Aug 2024, 13:49 |
| CYTH | Cyclo Therapeutics, Inc. | 03 Jun 2024 | 2 | $0 | 4 | Director | 05 Jun 2024, 17:08 |
| CYTH | Cyclo Therapeutics, Inc. | 13 Feb 2024 | 1 | $0 | 4 | Director | 15 Feb 2024, 16:42 |
| CYTH | Cyclo Therapeutics, Inc. | 28 Nov 2023 | 1 | $0 | 4 | Director | 30 Nov 2023, 09:06 |
| CYTH | Cyclo Therapeutics, Inc. | 17 Aug 2023 | 1 | $0 | 4 | Director | 21 Aug 2023, 09:00 |
| CYTH | Cyclo Therapeutics, Inc. | 17 Aug 2023 | 0 | $0 | 3 | Director | 21 Aug 2023, 09:00 |